Fenofibrate 48mg Tablets

Manufacturer AUROBINDO PHARMA Active Ingredient Fenofibrate and Derivatives Tablets(fen oh FYE brate & dah RIV ah tives) Pronunciation FEN-oh-FYE-brate
It is used to lower bad cholesterol, lower triglycerides, and raise good cholesterol (HDL).
🏷️
Drug Class
Antilipemic Agent
🧬
Pharmacologic Class
Fibrate; Peroxisome Proliferator-Activated Receptor Alpha (PPARΞ±) Agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Dec 1993
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fenofibrate is a medication used to lower high levels of cholesterol and triglycerides (fats) in your blood. It works by helping your body break down and remove these fats more effectively. Lowering these fats can help reduce your risk of heart disease and other health problems.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor. Read all the information provided with your prescription and follow the instructions carefully.
Check with your pharmacist to see if your specific brand of medication should be taken with food or if it can be taken with or without food.
If you have difficulty swallowing, consult with your doctor for guidance.
Take your medication with a full glass of water.
If you are taking cholestyramine or colestipol, be sure to take them at least 4 hours before or 1 hour after your medication.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.
Swallow your medication whole; do not chew, break, or crush it.
Do not take any tablets that are chipped or broken.

Storing and Disposing of Your Medication

To keep your medication effective and safe:

Store your medication at room temperature with the lid tightly closed.
Some brands of medication must be stored in their original container. Do not remove the anti-moisture cube or packet. If you are unsure, consult with your doctor or pharmacist.

What to Do if You Miss a Dose

If you miss a dose, follow these steps:

Skip the missed dose and return to your regular dosing schedule.
Do not take more than one dose in a 24-hour period, unless your doctor instructs you to do so.
πŸ’‘

Lifestyle & Tips

  • Take this medication exactly as prescribed, usually once daily with food.
  • Continue to follow a low-fat, low-cholesterol diet as recommended by your doctor.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Limit alcohol intake, as it can increase triglyceride levels and potentially worsen liver side effects.
  • Maintain a healthy weight.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 48 mg orally once daily with food
Dose Range: 48 - 145 mg

Condition-Specific Dosing:

primaryHypercholesterolemiaOrMixedDyslipidemia: Initial dose: 145 mg (or 48 mg for micronized/nanocrystallized equivalent) orally once daily. May be titrated up to 145 mg (or 48 mg equivalent) once daily. For 48mg formulation, the standard dose is 48mg once daily.
severeHypertriglyceridemia: Initial dose: 48 mg orally once daily. May be titrated up to 145 mg (or 48 mg equivalent) once daily. For 48mg formulation, the standard dose is 48mg once daily.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl 50-80 mL/min: No dose adjustment needed for 48mg formulation. Monitor renal function.
Moderate: CrCl 30-49 mL/min: Initial dose 48 mg every other day. Max dose 48 mg every other day. Avoid if CrCl < 30 mL/min.
Severe: CrCl < 30 mL/min: Contraindicated.
Dialysis: Contraindicated in patients with severe renal impairment, including those on dialysis.

Hepatic Impairment:

Mild: Not available
Moderate: Use with caution. Monitor liver function tests frequently.
Severe: Contraindicated in patients with active liver disease, including primary biliary cirrhosis and unexplained persistent liver function abnormalities.

Pharmacology

πŸ”¬

Mechanism of Action

Fenofibrate is a prodrug that is rapidly hydrolyzed to its active metabolite, fenofibric acid. Fenofibric acid activates peroxisome proliferator-activated receptor alpha (PPARΞ±), a nuclear receptor that regulates lipid metabolism. Through activation of PPARΞ±, fenofibric acid increases lipolysis and elimination of triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing production of apolipoprotein C-III (an inhibitor of lipoprotein lipase activity). It also increases the synthesis of apolipoproteins A-I and A-II, which are components of HDL-C. These actions result in reductions in total cholesterol, LDL-C, triglycerides, and increases in HDL-C.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Variable, enhanced with food. The 48mg formulation (e.g., Tricor, Lipofen) is micronized or nanocrystallized, leading to improved and more consistent absorption compared to older formulations.
Tmax: 4-5 hours (for fenofibric acid)
FoodEffect: Absorption is increased by approximately 35% when taken with food. The 48mg formulation is designed to be taken with food for optimal absorption.

Distribution:

Vd: Not readily available for fenofibric acid, but extensively distributed.
ProteinBinding: Greater than 99% (fenofibric acid) to plasma albumin.
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 20-23 hours (for fenofibric acid)
Clearance: Primarily renal clearance of fenofibric acid and its glucuronide conjugate.
ExcretionRoute: Mainly urine (approximately 60% as fenofibric acid and its glucuronide conjugate), some fecal excretion (approximately 25%).
Unchanged: Less than 1% (fenofibrate); negligible (fenofibric acid)
⏱️

Pharmacodynamics

OnsetOfAction: Lipid-lowering effects typically begin within days to weeks.
PeakEffect: Maximal lipid-lowering effects are usually observed within 6-8 weeks of therapy.
DurationOfAction: Effects persist as long as therapy is continued.

Safety & Warnings

⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be life-threatening.
Liver Problems: Dark urine, tiredness, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
Pancreas Problems (Pancreatitis): Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Gallstones: Sudden pain in the upper right belly area, right shoulder area, or between the shoulder blades, yellow skin or eyes, or fever with chills.
Severe Joint Pain or Swelling: Contact your doctor if you experience very bad joint pain or swelling.
Blood Clots: Chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, change of color, or pain in a leg or arm, or trouble speaking or swallowing.
Muscle Problems: Muscle pain or weakness, especially if you feel very tired or weak or have a fever. This can also lead to kidney problems. Inform your doctor if you have difficulty urinating or notice a change in your urine output.
Severe Skin Reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions can occur, which may affect body organs and can be deadly. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or any areas of skin; fever; chills; body aches; shortness of breath; or swollen glands.
Low Blood Cell Counts: This can lead to bleeding problems, infections, or anemia. Contact your doctor if you have signs of infection like fever, chills, or sore throat; any unexplained bruising or bleeding; or if you feel very tired or weak.

Other Side Effects

Most people do not experience significant side effects, but some may occur. If you are concerned about any of the following side effects or if they persist, contact your doctor:

Headache
Back pain
Stomach pain

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Muscle pain, tenderness, or weakness (especially if accompanied by fever or unusual tiredness) – report immediately.
  • Severe stomach pain, with or without nausea and vomiting (could be pancreatitis or gallstones).
  • Yellowing of your skin or eyes (jaundice), dark urine, or light-colored stools (signs of liver problems).
  • Unusual bleeding or bruising (if taking blood thinners).
  • Signs of an allergic reaction: rash, hives, swelling of your face, lips, tongue, or throat, difficulty breathing.
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the symptoms you experienced.
Certain health conditions, such as:
+ Gallbladder disease
+ Kidney disease
+ Liver disease
+ Elevated liver enzymes
If you are taking any of the following medications:
+ Atorvastatin
+ Fluvastatin
+ Lovastatin
+ Pitavastatin
+ Pravastatin
+ Rosuvastatin
+ Simvastatin
If you are breastfeeding or plan to breastfeed. Note that you should not breastfeed while taking this medication, and you may need to avoid breastfeeding for 5 days after your last dose. Consult your doctor to determine the best course of action.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter medications, natural products, and vitamins.
Discuss all your health problems with your doctor.
Verify that it is safe to take this medication with all your other medications and health conditions.
Do not start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regularly undergo blood tests and other laboratory examinations as instructed by your doctor. Adhere to the dietary and exercise plan recommended by your doctor.

Be aware that this medication can cause liver problems, which in some cases may be severe, potentially leading to the need for a liver transplant or resulting in death. If you have any concerns or questions, discuss them with your doctor.

If you are 65 years or older, exercise caution when using this drug, as you may be more susceptible to experiencing side effects.

If you are pregnant or planning to become pregnant, notify your doctor. It is crucial to discuss the potential benefits and risks associated with using this medication during pregnancy to make an informed decision.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • No specific symptoms of overdose have been reported, but potential effects could include severe gastrointestinal upset, liver dysfunction, or muscle toxicity.

What to Do:

There is no specific antidote for fenofibrate overdose. Treatment should be symptomatic and supportive. Hemodialysis is not effective in removing fenofibric acid. Call 1-800-222-1222 (Poison Control Center) immediately or seek emergency medical attention.

Drug Interactions

πŸ”΄

Major Interactions

  • Statins (HMG-CoA reductase inhibitors): Increased risk of myopathy/rhabdomyolysis. Use with caution, consider lower doses of statin, and monitor for muscle symptoms and CK levels.
  • Oral anticoagulants (e.g., Warfarin): Potentiates anticoagulant effect, increasing risk of bleeding. Reduce anticoagulant dose and monitor INR frequently.
  • Cyclosporine: May impair renal function, leading to increased fenofibric acid levels and potential for toxicity. Monitor renal function and fenofibric acid levels.
🟑

Moderate Interactions

  • Colchicine: Increased risk of myopathy/rhabdomyolysis. Use with caution.
  • Bile acid sequestrants (e.g., Cholestyramine, Colestipol): May decrease fenofibrate absorption. Administer fenofibrate at least 1 hour before or 4-6 hours after the bile acid sequestrant.
  • Glitazones (e.g., Pioglitazone, Rosiglitazone): Potential for additive effects on lipid parameters, but also increased risk of fluid retention and heart failure. Use with caution.

Monitoring

πŸ”¬

Baseline Monitoring

Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides)

Rationale: To establish baseline lipid levels and assess the need for therapy.

Timing: Prior to initiation of therapy

Liver Function Tests (ALT, AST, ALP, Bilirubin)

Rationale: To assess baseline liver function, as fenofibrate can cause transaminase elevations and is contraindicated in active liver disease.

Timing: Prior to initiation of therapy

Renal Function (Serum Creatinine, eGFR)

Rationale: To assess baseline renal function, as fenofibrate is primarily renally eliminated and dose adjustments are required in renal impairment.

Timing: Prior to initiation of therapy

Complete Blood Count (CBC)

Rationale: To assess for potential hematologic abnormalities, though rare.

Timing: Prior to initiation of therapy

πŸ“Š

Routine Monitoring

Lipid Panel

Frequency: Every 4-8 weeks initially, then every 6-12 months once stable

Target: Individualized based on treatment goals (e.g., LDL-C < 100 mg/dL, Triglycerides < 150 mg/dL)

Action Threshold: If lipid goals not met or adverse changes observed, consider dose adjustment or alternative therapy.

Liver Function Tests (ALT, AST)

Frequency: Every 3 months for the first year, then periodically (e.g., every 6-12 months) or as clinically indicated

Target: Within normal limits

Action Threshold: Discontinue if ALT or AST levels exceed 3 times the upper limit of normal (ULN) or if accompanied by symptoms of liver injury.

Renal Function (Serum Creatinine, eGFR)

Frequency: Periodically (e.g., every 6-12 months) or as clinically indicated, especially in elderly or those with pre-existing renal impairment

Target: Stable, within acceptable limits

Action Threshold: If significant increase in creatinine or decrease in eGFR, consider dose reduction or discontinuation.

Creatine Kinase (CK)

Frequency: As clinically indicated (e.g., if muscle pain, tenderness, or weakness occurs)

Target: Within normal limits

Action Threshold: Discontinue if CK levels are significantly elevated (e.g., >5x ULN) or if muscle symptoms are severe.

πŸ‘οΈ

Symptom Monitoring

  • Unexplained muscle pain, tenderness, or weakness (especially if accompanied by fever or malaise)
  • Abdominal pain, nausea, vomiting (signs of pancreatitis or gallstones)
  • Yellowing of skin or eyes (jaundice), dark urine, light-colored stools (signs of liver problems)
  • Unusual fatigue or weakness
  • Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should be avoided unless the potential benefit justifies the potential risk to the fetus. Limited human data suggest no increased risk of major birth defects, but animal studies show adverse effects at high doses.

Trimester-Specific Risks:

First Trimester: Limited human data, animal studies show teratogenicity at high doses. Avoid unless clearly needed.
Second Trimester: Limited human data. Continue to avoid unless clearly needed.
Third Trimester: Limited human data. Continue to avoid unless clearly needed.
🀱

Lactation

It is not known whether fenofibric acid is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderate risk) - Potential for serious adverse reactions in nursing infants. Consider alternatives or monitor infant closely.
πŸ‘Ά

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. Use is generally not recommended.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Renal function should be monitored.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fenofibrate 48mg is a micronized or nanocrystallized formulation, which has improved bioavailability compared to older, non-micronized formulations. It is not directly interchangeable milligram-for-milligram with older formulations (e.g., 160mg).
  • Always take fenofibrate with food to optimize absorption and efficacy.
  • Monitor liver function tests (LFTs) and renal function regularly, especially during the first year of treatment.
  • Educate patients on the signs and symptoms of myopathy (muscle pain, weakness) and pancreatitis (severe abdominal pain) and instruct them to report these immediately.
  • Fenofibrate can potentiate the effects of warfarin; close INR monitoring and dose adjustment of warfarin are crucial when initiating or discontinuing fenofibrate.
  • While fibrates can raise HDL-C and lower triglycerides, their primary role in cardiovascular risk reduction is often debated, and they are typically used when triglycerides are very high or in combination with statins for mixed dyslipidemia, with careful consideration of risks.
πŸ”„

Alternative Therapies

  • Other Fibrates (e.g., Gemfibrozil)
  • Statins (HMG-CoA reductase inhibitors) for hypercholesterolemia
  • Omega-3 Fatty Acid Esters (e.g., Icosapent ethyl, Omega-3-acid ethyl esters) for hypertriglyceridemia
  • PCSK9 Inhibitors (for severe hypercholesterolemia)
  • Niacin (Nicotinic Acid) for dyslipidemia (less commonly used due to side effects)
  • Bile Acid Sequestrants (for hypercholesterolemia)
πŸ’°

Cost & Coverage

Average Cost: $30 - $150 per 30 tablets (generic 48mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic), Tier 3 or higher (brand)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to ensure you receive the best possible care.